Connection

Paul Gurbel to Drug Resistance

Back to Details
This is a "connection" page, showing publications Paul Gurbel has written about Drug Resistance.
Paul Gurbel
Connection Strength
0.709
Drug Resistance
  1. Acetylsalicylic acid and clopidogrel hyporesponsiveness following acute coronary syndromes. Kardiol Pol. 2018; 76(9):1312-1319.
    View in: PubMed
    Score: 0.150
  2. Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention. Thromb Haemost. 2018 Jul; 118(7):1131-1140.
    View in: PubMed
    Score: 0.148
  3. Thromboembolism after WATCHMANTM in a clopidogrel non-responder: A case for concern? Catheter Cardiovasc Interv. 2018 07; 92(1):200-202.
    View in: PubMed
    Score: 0.143
  4. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. JACC Cardiovasc Interv. 2017 08 28; 10(16):1607-1617.
    View in: PubMed
    Score: 0.140
  5. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol. 2007 Nov 06; 50(19):1822-34.
    View in: PubMed
    Score: 0.071
  6. Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. Eur Heart J Cardiovasc Pharmacother. 2017 10 01; 3(4):221-234.
    View in: PubMed
    Score: 0.035
  7. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010 Sep 14; 56(12):919-33.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.